Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and ...

Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is based on ...

Celcuity Inc. (CELC) Presents at TD Cowen 46th Annual Health Care Conference Transcript

TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM ESTCompany ParticipantsBrian Sullivan - Co-Founder, Chairman ...
The 74 on MSN

‘Stage is shifting rapidly’ for high schools: Are states helping them keep up?

The 74 reports that a new XQ Institute study highlights the urgent need for high schools to adapt teaching methods for a tech ...

Ipsen Pharma: Ipsen voluntarily withdraws Tazverik (tazemetostat) in follicular lymphoma ...

PARIS, FRANCE, 09 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik (tazemetostat) in all indications from all Ipsen markets. Ipsen's decision ...